Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/ Ya Tsie trial
Authors/Creators
-
Magosi, Lerato1
- Zhang, Yinfeng2
-
Golubchik, Tanya3
- DeGruttola, Victor1
- Tchetgen Tchetgen, Eric4
- Novitsky, Vladimir1
- Moore, Janet5
- Bachanas, Pam5
- Segolodi, Tebogo5
- Lebelonyane, Refeletswe6
- Pretorius Holme, Molly1
-
Moyo, Sikhulile7
- Makhema, Joseph7
- Lockman, Shahin8
- Fraser, Christophe3
- Essex, Myron1
-
Lipsitch, Marc1
- 1. Harvard University
- 2. University of Pittsburgh Medical Center
- 3. University of Oxford
- 4. University of Pennsylvania
- 5. Centers for Disease Control and Prevention
- 6. Ministry of Health, Republic of Botswana*
- 7. Botswana Harvard AIDS Institute Partnership*
- 8. Brigham and Women's Hospital
Description
Background: Mathematical models predict that community-wide access to HIV testing-and-treatment can rapidly and substantially reduce new HIV infections. Yet several large universal test-and-treat HIV prevention trials in high-prevalence epidemics demonstrated variable reduction in population-level incidence.
Methods: To elucidate patterns of HIV spread in universal test-and-treat trials we quantified the contribution of geographic-location, gender, age and randomized-HIV-intervention to HIV transmissions in the 30-community Ya Tsie trial in Botswana (estimated trial population: 175,664).
Results: Deep-sequence phylogenetic analysis revealed that most inferred HIV transmissions within the trial occurred within the same or between neighboring communities, and between similarly-aged partners. Transmissions into intervention communities from control communities were more common than the reverse post-baseline (30% [12.2 – 56.7] versus 3% [0.1 – 27.3]) than at baseline (7% [1.5 – 25.3] versus 5% [0.9 – 22.9]) compatible with a benefit from treatment-as-prevention.
Conclusion: Our findings suggest that population mobility patterns are fundamental to HIV transmission dynamics and to the impact of HIV control strategies.
Funding: This study was supported by the National Institute of General Medical Sciences (U54GM088558); the Fogarty International Center (FIC) of the U.S. National Institutes of Health (D43 TW009610); and the President's Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention (CDC) (Cooperative agreements U01 GH000447 and U2G GH001911).
Notes
Files
metadata_bcpp_hiv_1c_viral_whole_genome_consensus_seqs_n382_magosi_etal_dryad_submission.csv
Additional details
Related works
- Is cited by
- 10.1101/2021.06.19.21259186 (DOI)